brentuximab vedotin

brentuximab vedotin
Trade Name Adcetris
Orphan Indication Mycosis fungoides
USA Market Approval USA
USA Designation Date 2012-11-19 00:00:00
Sponsor Seattle Genetics, Inc.;21823 30th Drive Southeast;Bothell, Washington, 98021